Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
The encouraging sales figures come at a time when treatment options for COPD patients have started ... the Biden administration has dropped the list of the next 15 drugs to be negotiated by ...